RUNX1 and acute myeloid leukemia: revealed that suppression of Fbp1, as well as pentose phosphate pathway enzymes by shRNA-mediated knockdown selectively decreased Evi1-driven leukemogenesis in vitro, Considering Evi1 upregulates Fbp1, and supports progression of AML through pentose phosphate pathway activation.